Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease.
Marianne E McPherson YeeGlaivy BatsuliSatheesh ChonatSunita ParkPublished in: Clinical case reports (2020)
Thrombocytosis is common in sickle cell disease and may contribute to vaso-occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.